ACE Inhibitor
Class of medicines used to treat high blood pressure and other diseases.
Activating factor
A functioning plasma protein that works in the coagulation pathway to help form a clot.
Anabolic steroid
Also referred to as attenuated androgen, a class of steroid hormones used to prevent HAE attacks. Although their mechanism of action in HAE patients is unknown, these agents are believed to partially reverse the biochemical defect by increasing levels of C1-esterase inhibitor (C1-INH), helping to prevent angioedema attacks in patients with inherited C1-INH deficiency.
Antifibrolytic agent
Medicines used to prevent HAE attacks. These agents inhibit the activation of plasmin, a chemical in the blood that can make the C1-INH less effective.
Attenuated androgen
Also referred to as anabolic steroid, a class of steroid hormones used to prevent HAE attacks. Although their mechanism of action in HAE patients is unknown, these agents are believed to partially reverse the biochemical defect by increasing levels of C1-esterase inhibitor (C1-INH), helping to prevent angioedema attacks in patients with inherited C1-INH deficiency.
Bradykinin
A protein, which when released, causes blood vessels to expand (dilate) and leak fluid, such as serum, into surrounding tissue.
C1 inhibitor
Also referred to as C1-INH, a protein found in the fluid part of your blood that controls C1, a component of your body's complement system. Abnormal swelling can result when C1-INH is insufficient or defective.
C1-INH
Also referred to as C1 inhibitor, a protein found in the fluid part of your blood that controls C1, a component of your body's complement system. Abnormal swelling can result when C1-INH is insufficient or defective.
Cleave
To cut; to split
Coagulation pathway
A process in which blood cells work together to form a clot.
Complement system
The complement system is made up of proteins like C1 that float in your bloodstream, which work with the immune system to fight organisms like bacteria, viruses and parasites.
Drug formulary
A list of prescription medications selected for coverage under a health insurance plan.
Edema
Swelling caused by an excessive amount of fluid in the body tissues.
Endothelial cells
A thin layer of cells that line the surface of blood vessels.
Enzyme
A protein that changes the rate of chemical reactions in the body.
HAE
HAE, or Hereditary Angioedema, is a rare, hereditary disease of the immune system that affects an estimated 1 in 10,000 to 1 in 50,000 adults and children globally. HAE causes attacks of spontaneous swelling that are often painful and severe, and can be life-threatening.
Hereditary Angioedema
A rare, hereditary disease of the immune system that affects an estimated 1 in 10,000 to 1 in 50,000 adults and children globally. Hereditary Angioedema (HAE) causes attacks of spontaneous swelling that are often painful and severe, and can be life-threatening.
High-molecular-weight kininogen
HMWK, a protein that acts on the inflammation and coagulation processes; inactive until it is cleaved by kallikrein and in turn, releases bradykinin.
Hypotension
Low blood pressure.
Inflammatory pathway
A process in which the body responds to an injury either inside or outside of the body.
Inhibitor
That which reduces, prevents or stops; i.e. a substance that stops enzyme activity.
Kallikrein–kinin system
A system of proteins in the blood that has a role in the inflammatory pathway; through this system, bradykinin is released.
Kinin
A protein that is a component of the kallikrein-kinin system.
Laryngeal attack
An HAE attack that affects the larynx (throat); this can block or close the airway, leading to difficulty breathing and, potentially, death.
Liberate
To release
Plasma kallikrein
An enzyme present in blood plasma, urine and tissue; responsible for cleaving high-molecular-weight kininogen (HMWK), which then releases bradykinin.
Prekallikrein
Precursor to kallikrein; inactive until it cleaved by activated factor (specifically, activated factor XII) to generate active kallikrein.
Preventive therapy
In HAE, medicine taken to prevent attacks.
Prodrome
One or more physical warnings of an HAE attack; can appear as a rash or a feeling of skin tightness.
Protease
An enzyme that breaks proteins down into a simpler form.
Proteolytic cascade
A step-by-step process in which proteins are broken down into simpler forms.
Receptor
A component in a cell that can combine with a drug or a chemical in the body (i.e. hormone) to change the function of the cell.
Serum
The clear, watery, fluid-component of blood that resembles fluid in a blister.
Subcutaneous
Beneath the skin.
Substrate
A molecule or substance acted upon by an enzyme.
Trigger
In HAE, something that causes an attack. Stress and trauma are two common HAE attack triggers.
Vascular permeability
The capacity of blood vessels to allow fluids or molecules to pass in and out of the vessel.
Vasodilator
A substance that opens, or dilates, blood vessels; e.g. bradykinin and nitric oxide.
Header: HAE Attacks
print friendly

Symptoms

The frequency, severity, and location of HAE symptoms can vary widely, even in the same patient.

Many patients experience a "prodrome" one-half hour to several hours before an HAE attack. A prodrome is basically one or more warning signs that an attack is coming, such as:

  • A painless, non-itchy rash that may be “S”-shaped; the rash may not necessarily occur in the same location as the attack
  • Tingling or a sensation of tightness in an area of skin that later becomes swollen

When HAE Attacks Happen

On average, untreated HAE patients experience greater than 20 attacks per year, each generally lasting between 2 and 5 days.

When an attack occurs, the symptoms typically worsen for the first 24-36 hours, then slowly resolve during the next 36-48 hours. Attacks frequently result in hospitalization, may lead to unneeded abdominal surgery, and can be life-threatening when involving the airway.

Once the symptoms have resolved, most HAE patients are relatively unlikely to experience another HAE attack for approximately a week. Many patients with untreated HAE have a natural attack frequency of every 10 to 14 days.

Subcutaneous Swelling

Most HAE attacks involve swelling of the face, extremities (hands and feet), or genitals. This type of attack affects the subcutaneous tissue, or the tissue just beneath the skin. Although uncomfortable and disfiguring, the swelling is usually painless unless it occurs in a pressure-bearing area or in an area with little subcutaneous tissue.

Facial swelling most often involves the lips, eyelids, or tongue; the swelling is sometimes accompanied by redness that looks like a rash, although it doesn't itch. These attacks, while uncomfortable and disfiguring, are usually painless.

Abdominal Attacks

The abdomen is the second most common site of HAE attacks. Abdominal attacks have been reported in more than 93% of patients and make up almost 50% of all angioedema attacks.

Swelling of the gastrointestinal tract can cause nausea, vomiting, and severe pain, and is rarely accompanied by fever. Abdominal symptoms usually resolve more quickly than other attack locations, and diarrhea may occur as the attack subsides.

An abdominal attack may be hard to distinguish from other abdominal ailments. In fact, many HAE patients undergo unnecessary surgery, particularly before their disease is diagnosed. In one review of 235 HAE patients, 34% had an appendectomy and/or exploratory laparotomy during an attack.

Laryngeal Attacks

Although much less common than the other types of attacks, swelling of the larynx (laryngeal attacks) is the most dangerous, because it can obstruct the airway. Research indicates that in patients with undiagnosed HAE, mortality has been reported to be as high as 40% as a result of a laryngeal attack.

Approximately 50% of all HAE patients experience a laryngeal attack at least once in their lifetime, and some patients have them repeatedly. Laryngeal attacks can occur at any age, but are most common in patients between the ages of 11 and 45. These attacks are especially dangerous in young children, who have small airways.

Less than 5% of laryngeal attacks are linked to an identifiable trigger. Attacks may begin with difficulty swallowing and a change in voice tone. They usually develop over a period of hours, but can occur in as rapidly as 20 minutes. 

This type of attack is an emergency - seek medical treatment immediately. Always carry an HAE wallet card  or a letter from your doctor with you in case you have an attack and are unable to speak.

 

Sign up for our email newsletter and get informed of the latest HAE news.

sign up now

 

PRIVACY POLICY | TERMS OF USE | SITEMAP | Home | About HAE | HAE Attacks | Treating HAE | Living with HAE | HAE Perspectives | Register | Contact Us

You are now leaving HAEHope.com.
The web site you are about to visit is neither owned nor controlled by Dyax Corp. Dyax is not responsible for the content, products or services on this site.

Do you wish to continue?